# Preterm-birth prevention with progesterone

A living systematic review

**Alert**
Prior M, Hibberd R, Asemota N, Thornton JG. Inadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis. BJOG. 2017 Mar 20. doi: 10.1111/1471-0528.14506. [Epub 
ahead of print] Review. PubMed PMID: [28318099](http://pubmed.gov/28318099)

**Clinical summary:** This meta-analysis suggests that intramuscular progesterone *is* effective at reducing neonatal mortality and preterm birth (< 34 weeks). 

[Keep current with this topic](Keep-up.md) (under development)

**Methods overview:** This repository is an [openMetaAnalysis](https://openmetaanalysis.github.io/) that updates a previously published meta-analysis.(1) Newer studies included are listed in the references below. Rationale for newer trials excluded may be listed at the end of the references. 

This repository is a limited review and contains outcomes data only without PICO and Risk of Bias Tables.  This review does not include a GRADE Profile or Summary of Findings Table.

* [Methods](http://openmetaanalysis.github.io/methods.html) for openMetaAnalysis
* [Evidence search](evidence-search.md) for this review (under development)

**Results:** Details of the studies included are in the:
* [Description of studies (PICO table)](../../tree/master/files/study-details/pico-table.md) (not available)
* [Risk of bias assessment](../../tree/master/study-details/risk-of-bias.md) (not available)
* [Forest plots](../../tree/master/forest-plots) ([source data](../../tree/master/files/data))
* [Reconciliation of conclusions and trials included with prior meta-analyses](../../tree/master/files/reconcilation-tables) (not available)

The forest plot for the primary outcomes are below. Additional [forest plots](../../tree/master/files/forest-plots) of secondary analyses may be available. 

![Principle results for benefit](https://raw.githubusercontent.com/openMetaAnalysis/Preterm-birth-prevention-with-progesterone/master/files/forest-plots/Outcome-Primary.png "Principle results for benefit]")

birth![Principle results for benefit](https://raw.githubusercontent.com/openMetaAnalysis/Preterm-birth-prevention-with-progesterone/master/files/forest-plots/Outcome-Perinatal.png "Principle results for benefit]")

References:
----------------------------------
### Systematic review(s)
#### Most recent review(s) at time of last revision of this repository
1. Dodd JM, Grivell RM, OBrien CM, Dowswell T, Deussen AR. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy. Cochrane Database Syst Rev. 2017 Oct 31;10:CD012024. doi: 10.1002/14651858.CD012024.pub2. PMID: [29086920](http://pubmed.gov/29086920).
2. Prior M, Hibberd R, Asemota N, Thornton JG. Inadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis. BJOG. 2017 Mar 20. doi: 10.1111/1471-0528.14506. PMID: [28318099](http://pubmed.gov/28318099)
3. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013 Jul 31;(7):CD004947. doi:10.1002/14651858.CD004947.pub3. PMID: [23903965](http://pubmed.gov/23903965)
4. Saccone G, Schoen C, Franasiak JM, Scott RT Jr, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2016 Nov 22. doi: 10.1016/j.fertnstert.2016.10.031. PMID: [27887710](http://pubmed.gov/27887710)

### Randomized controlled trials that are more recent
1. Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J; OPPTIMUM study group.. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet. 2016 May 21;387(10033):2106-16. doi: [10.1016/S0140-6736(16)00350-0](http://dx.doi.org/10.1016/S0140-6736(16)00350-0). PMID: [26921136](http://pubmed.gov/26921136)
2. Azargoon A, Ghorbani R, Aslebahar F. Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study. Int J Reprod Biomed (Yazd). 2016 May;14(5):309-16. PMID: [27326415](http://pubmed.gov/27326415); PMCID: [PMC4910039](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910039/)

#### New study(s) undergoing review
1. Conde-Agudelo A, Romero R, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Erez O, Pacora P, Nicolaides KH. Vaginal Progesterone is as Effective as Cervical Cerclage to Prevent Preterm Birth in Women with a Singleton Gestation, Previous Spontaneous Preterm Birth and a Short Cervix: Updated Indirect Comparison Meta-Analysis. Am J Obstet Gynecol. 2018 Apr 6. pii: S0002-9378(18)30243-6. doi: 10.1016/j.ajog.2018.03.028. [Epub ahead of print] PMID: [29630885](http://pubmed.gov/29630885).
1. Palacio M, Cobo T, Antolın E, Ramirez M, Cabrera F, Mozo de Rosales F, et al. Vaginal progesterone as maintenance treatment
after an episode of preterm labor (PROMISE Study): a randomized, double blinded, placebo-controlled trial. Am J Obstet Gynecol
2013;208:S10–1.
1. Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, et al; 4P trial group.. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG. 2015 Jan;122(1):80-91. PMID [25209926](http://pubmed.gov/25209926)
2. Winer N, Bretelle F, Senat MV, Bohec C, Deruelle P, Perrotin F, Connan L, Vayssière C, Langer B, Capelle M, Azimi S, Porcher R, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie.. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. Am J Obstet Gynecol. 2015 PMID: [25448515](http://pubmed.gov/25448515)
3. Hernandez WR, Francisco RPV, Bittar RE, Gomez UT, Zugaib M, Brizot ML. Effect of vaginal progesterone in tocolytic therapy during preterm labor in twin pregnancies: Secondary analysis of a placebo-controlled randomized trial. J Obstet Gynaecol Res. 2017 Jul 14. doi: 10.1111/jog.13421. PMID: [28707771](http://pubmed.gov/28707771)
4. Choi SJ. Use of progesterone supplement therapy for prevention of preterm birth: review of literatures. Obstet Gynecol Sci. 2017 Sep;60(5):405-420. doi: 10.5468/ogs.2017.60.5.405. Epub 2017 Sep 18. PMID: [28989916](http://pubmed.gov/28989916).
5. Romero R, Conde-Agudelo A, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Nicolaides KH. Vaginal Progesterone for Preventing Preterm Birth and Adverse Perinatal Outcomes in Singleton Gestations with a Short Cervix: A Meta-Analysis of Individual Patient Data. Am J Obstet Gynecol. 2017 Nov 16. pii: S0002-9378(17)32343-8. doi: 10.1016/j.ajog.2017.11.576. PMID: [29157866](http://pubmed.gov/29157866).
6. Stewart LA, Simmonds M, Duley L, et al; EPPPIC group. Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol. Syst Rev. 2017 Nov 28;6(1):235. doi: 10.1186/s13643-017-0600-x. PMID: [29183399](http://pubmed.gov/29183399).
7. Shambhavi S, Bagga R, Bansal P, Kalra J, Kumar P. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. J Obstet Gynaecol. 2018 Mar 20:1-7. doi: [10.1080/01443615.2018.1425380](http://dx.doi.org/10.1080/01443615.2018.1425380). PMID: [29557230](http://pubmed.gov/29557230)
8. 1: Quist-Nelson J, Parker P, Mokhtari N, Di Sarno R, Saccone G, Berghella V. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2018 Mar 31. pii: S0002-9378(18)30242-4. doi: [10.1016/j.ajog.2018.03.027](http://dx.doi.org/10.1016/j.ajog.2018.03.027). [Epub ahead of print] Review. PMID: [29614278](http://pubmed.gov/29614278).





#### New study(s) *excluded* 
None

-------------------------------
[Cite and use this content](https://github.com/openMetaAnalysis/openMetaAnalysis.github.io/blob/master/reusing.MD)  - [Edit this page](../../edit/master/README.md) - [History](../../commits/master/README.md)  - 
[Issues and comments](../../issues?q=is%3Aboth+is%3Aissue)

